Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-25

Clinical Trial Update: Evaluate Safety and Efficacy of AEGR-733 and Atorvastatin vs Atorvastatin Monotherapy in Hypercholesterolemia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing AEGR-733 plus atorvastatin to atorvastatin monotherapy in hypercholesterolemia; results posted on 2013-02-25.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AEGR-733
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Aegerion Pharmaceuticals, Inc. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2013-02-25